Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group

PURPOSE: While gemtuzumab ozogamicin (GTMZ) is commonly used in the treatment of acute myeloid leukemia (AML) in combination with standard chemotherapy agents, the pediatric maximum-tolerated dose (MTD) of GMTZ in combination with chemotherapy has not been determined. PATIENTS AND METHODS: The Child...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Aplenc, Richard, Alonzo, Todd A., Gerbing, Robert B., Lange, Beverly J., Hurwitz, Craig A., Wells, Robert J., Bernstein, Irwin, Buckley, Patrick, Krimmel, Kathleen, Smith, Franklin O., Sievers, Eric L., Arceci, Robert J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2008
Soggetti:
Pediatric Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558626/
https://ncbi.nlm.nih.gov/pubmed/18467731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.0096
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi